|
Immunotherapy
Citations 401-410 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
- Nicolas Mounier, Josette Briere, Christian Gisselbrecht, Jean-Francois Emile, Pierre Lederlin, Catherine Sebban, Francoise Berger, Andre Bosly, Pierre Morel, Herve Tilly, Reda Bouabdallah, Felix Reyes, Philippe Gaulard, and Bertrand Coiffier
Blood 2003; 101: 4279-4284.
[Abstract]
[Full text]
[PDF]
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
- Bradley C. Ekstrand, Jennifer B. Lucas, Steven M. Horwitz, Zhen Fan, Sheila Breslin, Richard T. Hoppe, Yasodha Natkunam, Nancy L. Bartlett, and Sandra J. Horning
Blood 2003; 101: 4285-4289.
[Abstract]
[Full text]
[PDF]
Rapamycin inhibits IL-4—induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo
- Holger Hackstein, Timucin Taner, Alan F. Zahorchak, Adrian E. Morelli, Alison J. Logar, Andre Gessner, and Angus W. Thomson
Blood 2003; 101: 4457-4463.
[Abstract]
[Full text]
[PDF]
Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity
- Yi Zeng, Hanping Feng, Michael W. Graner, and Emmanuel Katsanis
Blood 2003; 101: 4485-4491.
[Abstract]
[Full text]
[PDF]
Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress–induced apoptosis
- Rosalie M. Luiten, Jérôme Pène, Hans Yssel, and Hergen Spits
Blood 2003; 101: 4512-4519.
[Abstract]
[Full text]
[PDF]
Signaling through MHC in transgenic mice generates a population of memory phenotype cytolytic cells that lack TCR
- Hugh I. McFarland, Susan A. Hansal, Diane I. Morris, Daniel W. McVicar, Paul E. Love, and Amy S. Rosenberg
Blood 2003; 101: 4520-4528.
[Abstract]
[Full text]
[PDF]
Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells
- Thomas Rasmussen, Lotta Hansson, Anders Österborg, Hans Erik Johnsen, and Håkan Mellstedt
Blood 2003; 101: 4607-4610.
[Abstract]
[Full text]
[PDF]
Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon  with an anti-CD20
- Domenico Sansonno, Valli De Re, Gianfranco Lauletta, Felicia Anna Tucci, Mauro Boiocchi, and Franco Dammacco
Blood 2003; 101: 3818-3826.
[Abstract]
[Full text]
[PDF]
Efficacy and safety of rituximab in type II mixed cryoglobulinemia
- Francesco Zaja, Salvatore De Vita, Cesare Mazzaro, Stefania Sacco, Daniela Damiani, Ginevra De Marchi, Angela Michelutti, Michele Baccarani, Renato Fanin, and Gianfranco Ferraccioli
Blood 2003; 101: 3827-3834.
[Abstract]
[Full text]
[PDF]
Rituximab for the treatment of refractory autoimmune hemolytic anemia in children
- Marco Zecca, Bruno Nobili, Ugo Ramenghi, Silverio Perrotta, Giovanni Amendola, Pasquale Rosito, Momcilo Jankovic, Paolo Pierani, Piero De Stefano, Mario Regazzi Bonora, and Franco Locatelli
Blood 2003; 101: 3857-3861.
[Abstract]
[Full text]
[PDF]
|
|
